28th Sep 2023 7:00 am |
RNS |
Interim Results for the Period Ending 30 June 2023 |
20th Sep 2023 2:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
20th Sep 2023 7:01 am |
RNS |
Peel Hunt Appointed as Joint Broker |
20th Sep 2023 7:00 am |
RNS |
Appointment Dr.Christina Coughlin as a consultant |
19th Sep 2023 7:00 am |
RNS |
Successful Completion of Sixth Dose Escalation |
6th Sep 2023 7:00 am |
RNS |
Notice of Results |
21st Jul 2023 3:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
28th Jun 2023 11:00 am |
RNS |
Result of Annual General Meeting |
28th Jun 2023 7:00 am |
RNS |
Annual General Meeting and Shareholder Event |
21st Jun 2023 7:00 am |
RNS |
Completion of Fifth Dose Escalation in AVA6000 |
19th Jun 2023 7:01 am |
RNS |
Director Appointment |
19th Jun 2023 7:00 am |
RNS |
Statement regarding market speculation |
8th Jun 2023 7:00 am |
RNS |
AGM and Shareholder Event Detailed Agenda |
5th Jun 2023 7:00 am |
RNS |
Second Milestone in AffyXell Joint Venture |
2nd Jun 2023 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
1st Jun 2023 7:00 am |
RNS |
Avacta acquires Coris Bioconcept |
27th Apr 2023 7:00 am |
RNS |
Block Listing Six Monthly Return |
27th Apr 2023 7:00 am |
RNS |
First Patient Dosed in the US in AVA6000 Phase 1 |
25th Apr 2023 7:00 am |
RNS |
Preliminary Results |
21st Apr 2023 2:49 pm |
RNS |
Issue of Equity and Total Voting Rights |
17th Apr 2023 7:00 am |
RNS |
AVA3996 data poster presented at AACR |
6th Apr 2023 7:00 am |
RNS |
1st US Clinical Investigator AVA6000 Sites Opened |
5th Apr 2023 7:00 am |
RNS |
First Patient Dosed in Fifth Cohort of AVA6000 |
3rd Apr 2023 7:00 am |
RNS |
Notice of Results and Investor Presentation |
27th Mar 2023 7:00 am |
RNS |
AVA3996 data poster presentation at AACR |
13th Mar 2023 7:00 am |
RNS |
Statement re: Silicon Valley Bank |
23rd Feb 2023 7:00 am |
RNS |
Avacta Therapeutics Division Science Day |
13th Feb 2023 7:00 am |
RNS |
Issue of Equity and Total Voting Rights |
23rd Jan 2023 12:20 pm |
RNS |
Issue of Equity and Total Voting Rights |
17th Jan 2023 2:05 pm |
RNS |
Second Price Monitoring Extn |
17th Jan 2023 2:00 pm |
RNS |
Price Monitoring Extension |
17th Jan 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
17th Jan 2023 11:00 am |
RNS |
Price Monitoring Extension |
17th Jan 2023 9:05 am |
RNS |
Second Price Monitoring Extn |
17th Jan 2023 9:00 am |
RNS |
Price Monitoring Extension |
17th Jan 2023 7:00 am |
RNS |
Successful Completion of Fourth Dose Escalation |
16th Jan 2023 10:15 am |
RNS |
Block Listing Application to AIM |
19th Dec 2022 7:00 am |
RNS |
Avacta to Host Therapeutics Division Science Day |
8th Nov 2022 7:01 am |
RNS |
Director/PDMR Shareholding |
8th Nov 2022 7:00 am |
RNS |
Result of the Open Offer |